Absence of central cholinergic deficits in ApoE knockout mice

Psychopharmacology

Volumn 132, Issue 2, 1997, Pages 135-144

  Anderson, R ^a   Higgins, G A ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Alzheimer's disease; ApolipoproteinE; Cholinergic system; E2020 (donepezil); Transgenic mice

Indexed keywords

APOLIPOPROTEIN E; CHOLINE ACETYLTRANSFERASE; DONEPEZIL; METHYLSCOPOLAMINE; SCOPOLAMINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CHOLESTEROL BLOOD LEVEL; CHOLINERGIC SYSTEM; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; DELETION MUTANT; ENTORHINAL CORTEX; ENZYME ACTIVITY; FEMALE; FRONTAL CORTEX; GENOTYPE; HIPPOCAMPUS; HISTOCHEMISTRY; HUMAN; HYPOTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MAZE TEST; MOUSE; PRIORITY JOURNAL; RISK FACTOR; TRANSGENIC MOUSE;

ACETYLCHOLINESTERASE; ANIMALS; APOLIPOPROTEINS E; BODY TEMPERATURE; BRAIN; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC AGONISTS; FEMALE; INDANS; MALE; MAZE LEARNING; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MOTOR ACTIVITY; PIPERIDINES; RECEPTORS, CHOLINERGIC;

EID: 0030877056     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050329     Document Type: Article

References (49)

1. Aguzzi A, Brandner S, Sure U, Ruedi D, Isenmann S (1994) Transgenic and knock-out mice: models of neurological disease. Brain Pathol 4: 3-20
2. Buresova O, Bolhuis JJ, Bures J (1986) Differential effects of cholinergic blockade on performance of rats in the water tank navigation task and in a radial water maze. Behav Neurosci 100: 476-482
3. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923
4. Corder EH, Saunders AM, Risch NJ, Strittmater WJ, Schmechel, DE, Gaskell PC, Jr Rimmler JB, Locke PA, Conneally PM, Schmader KE, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1994) Protective effect of apolipoprotein E type 2 allele for late-onset Alzheimer's disease. Nature Genet 7: 180-184
5. Crawley JN (1996) Unusual behavioural phenotypes of inbred mouse strains. Trends Neurosci 19: 181-182
6. Dawson GR, Iversen SD (1993) The effects of novel cholinesterase inhibitors and selective muscarinic receptor agonists in tests of reference and working memory. Behav Brain Res 57: 143-153
7. Dong GZ, Kameyama K, Rinken A, Haga T (1995) Ligand binding properties of muscarinic acetylcholine receptor subtypes (m1-m5) expressed in Baculovirus-infected insect cells. J Pharmacol Exp Ther 274: 378-384
8. Dunnett SB (1985) Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats. Psychopharmacology 87: 357-363
9. Farlow M, Gracon SI, Hershey LA, Lewis KW, Sadowsky CH, Dolan-Ureno J (1992) A controlled trial of tacrine in Alzheimer's disease. JAMA 258: 2523-2529
10. Fonnum F (1969a) Isolation of choline esters from aqueous solutions by extraction with sodium tetraphenylboron in organic solvents. Biochem J 113: 291-298
11. Fonnum F (1969b) Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities. Biochem J 115: 465-472
12. Fonnun F (1975) A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem 24: 407-409
13. Gerlai R (1996) Gene-targeting studies of mamalian behaviour: is it the mutation or the background genotype? Trends Neurosci 19: 177-181
14. Gordon I, Grauer E, Genis I, Sehayek E, Michaelson DM (1995) Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci Lett 199: 1-4
15. Hagan JJ, Salamone JD, Simpson J, Iversen SD, Morris RGM (1988) Place navigation in rats is impaired by lesions of medial septum and diagonal band but not nucleus basalis magnocellularis. Behav Brain Res 27: 9-20
16. Henke H, Lang W (1983) Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of Alzheimer-type patients. Brain Res 267: 281-291
17. Higgins GA, Large CH, Rupniak HT, Barnes J (1997) Apolipoprotein E and Alzheimer's disease: a review of recent studies. Pharmacol Biochem Behav (in press)
18. Kawashima K, Sato A, Yoshizawa M, Fujii T, Fujimoto K, Suzuki T (1994) Effects of the centrally acting cholinesterase inhibitors tetrahydroaminoacridine and E2020 on the basal concentration of extracellular acetylcholine in the hippocampus of freely moving rats. Naunyn-Schmiedeberg's Arch Pharmacol 350: 523-528
19. 3 antagonist thioperamide, in models of cognition and cholinergic function. Behav Pharmacol 7: 513-525
20. Knapp MJ, Knopman DS, Soloman PR, Pendlebury WW, Davis CS, Gracon SI (1994) A 30-week randomized controlled trial of high dose tacrine in patients with Alzheimer's disease. JAMA 271: 985-1024
21. Kuipers F, Van Ree JM, Hofker MH, Wolters H, In't Veld G, Havinga R, Vonk RJ, Princen HMG, Havekes LM (1996) Altered lipid metabolism in apolipoprotein E-deficient mice does not affect cholesterol balance across the liver. Hepatology 24: 241-247
22. McFarland DJ (1989) Effects of scopolamine, D-amphetamine and apomorphine on alternation and position bias. Pharmacol Biochem Behav 32: 723-726
23. Mahley RW (1988) Apolipoprotein E. Cholesterol transport protein with expanding role in cell biology. Science 240: 622-630
24. Masliah E, Mallory M, Ge N, Alford M, Veinbergs I, Roses AD (1995a) Neurodegeneration in the central nervous system of apoE deficient mice. Exp Neurol 136: 107-122
25. Masliah E, Mallory M, Alford M, Ge N, Mucke L (1995b) Abnormal synaptic regeneration in hAPP695 transgenic and ApoE knockout mice. In: Iqbal K, Mortimer JA, Winblad B, Wisniewski HM (eds) Research advances in Alzheimer's disease and related disorders. Wiley, New York, pp 405-414
26. Perry EK (1986) The cholinergic hypothesis - ten years on. BMJ 42: 63-69
27. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N (1992) Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci USA 89: 4471-4475
28. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL (1992) Severe hypercholesterolaemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71: 343-353
29. Poirier J (1994) Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurol Sci 17: 525-530
30. Poirier J, Baccichet A, Dea D, Gauthier S (1993) Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience 55: 81-90
31. Poirier J, Delisle M-C, Quirion R, Aubert I, Farlow M, Lahir D, Hui S, Bertrand P, Nalbantoglu J, Gilfix BM, Gauthier S (1995) Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer's disease. Proc Natl Acad Sci USA 92: 12260-12264
32. Popko B, Goodrum JF, Bouldin TW, Zhang SH, Maeda N (1993) Nerve regeneration occurs in the absence of apolipoprotein E in mice. J Neurochem 60: 1155-1158
33. Rogers SL, Friedfoff LT (1996) The efficacy and safety of donepezil in patients with Alzheimers Disease: results from a US multicentre, randomized, double-blind, placebo-controlled trial. Dementia 7: 293-303
34. Rogers SL, Yamanishi Y, Yamatsu K (1991) The pharmacology of piperidine cholinesterase inhibitor. In: Becker R, Giacobini E (eds) Cholinergic basis for Alzheimer therapy. Birkhäuser, Boston, pp 314-320
35. Rose S (1995) The rise of neurogenetic determinism. Nature 373: 380-382
36. Sarter M, Bodewitz G, Stephens DN (1988) Attenuation of scopolamine-induced impairment of spontaneous alternation behaviour by antagonist but not inverse agonist and antagonist β-carbolines. Psychopharmacology 94: 491-495
37. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-Maclachlan DR, Alberts MJ (1993) Association of apolipoprotein E allele epsilon 4 with late onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472
38. Soininen H, Kosunen O, Helisalmi S, Mannermaa A, Paljarvi L, Talasniemi S, Ryynanen M, Riekkinen P (1995) A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein e4 allele. Neurosci Lett 187: 79-82
39. Strittmatter WJ, Weisgraber KH, Huang DY, Dong L, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD (1993) Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer's disease. Proc Natl Acad Sci USA 90: 8098-8102
40. Strittmatter WJ, Saunders AM, Goedert M, Weisgraber KH, Dong L, Jakes R, Huang DY, Pericak-Vance M, Schmechel D, Roses AD (1994) Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer's disease. Proc Natl Acad Sci USA 91: 11183-11186
41. Sutherland RJ, Rudy JW (1989) Configurai association theory: the role of the hippocampal formation in learning, memory and amnesia. Psychobiology 17: 129-144
42. Suzuki M, Yamaguchi T, Ozawa Y, Ohyama M, Yamamoto M (1995) Effects of (-)-S-02,8-dimethyl-3-methylene-1-oxa-8-azaspiro[4, 5]decane L-tartrate monohydrate (YM796), a novel muscarinic agonist, on disturbance of passive avoidance learning behaviour in drug-treated and senescence-accelerated mice. J Pharmacol Exp Ther 275: 728-736
43. Ukai M, Shinkai N, Kameyama T (1995) Cholinergic receptor agonists inhibit pirenzepine-induced dysfunction of spontaneous alternation performance in the mouse. Gen Pharmacol 26: 1526-1532
44. Weisgraber KH (1994) Apolipoprotein E: structure-function relationships. Adv Protein Chem 45: 249-302
45. Weisgraber KH, Roses AD, Strittmatter WJ (1994) The role of apolipoprotein E in the nervous system. Curr Opin Lipidol 5: 110-116
46. Wolfer DP, Bozicevic-Stagliar M, Lipp H-P (1995) The role of genetic background in assessing the behaviour of transgenic mice. Soc Neurosci Abstr 21: 480.15. p 1227
47. Xu P-T, Schmechel D, Rothrock-Christian T, Scott Burkhart D, Qiu H-L, Popko B, Sullivan P, Maedu N, Saunders AM, Roses AD, Gilbert JR (1996) Human apolipoprotein E2, E3 and E4 isoform specific transgenic mice: human-like pattern of neuronal immunoreactivity in central nervous system not observed in wild type mice. Neurobiol Dis 3: 229-245
48. Zhang SH, Reddick RL, Piedrahita JA, Macda N (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258: 468-171
49. 1. Biochem Biophys Res Commun 205: 1431-1437